4,5,6,7-Tetrahydrothiazolo[5,4-c]pyridine hydrochloride

Catalog No. :
ACWBOI430
CAS No. :
1241725-84-7
Molecular Formula :
C6H9ClN2S
Molecular Weight :
176.67

IUPAC Name:4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine hydrochloride

4,5,6,7-Tetrahydrothiazolo[5,4-c]pyridine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$64.00Login to see priceIn stockIn stock
250mg98%$97.00Login to see priceIn stockIn stock
1g98%$259.00Login to see priceIn stockInquiry
5g98%$775.00Login to see priceIn stockInquiry
25g98%$2883.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4,5,6,7-Tetrahydrothiazolo[5,4-c]pyridine hydrochloride
IUPAC Name4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine hydrochloride
MDL No.MFCD08726044
Molecular FormulaC6H9ClN2S
Molecular Weight176.67
SMILESCl.C1CC2=C(CN1)SC=N2
InChI KeyKHTQBEIQKYEJEI-UHFFFAOYSA-N
Synonym4,5,6,7-Tetrahydrothiazolo[5,4-c]pyridine hydrochloride | 1241725-84-7 | 4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE HCL | 4,5,6,7-Tetrahydrothiazolo-[5,4-c]pyridine hydrochloride | 4,5,6,7-tetrahydro-[1,3]thiazolo[5,4-c]pyridine;hydrochloride | Thiazolo[5,4-c]pyridi
CAS No.1241725-84-7
PubChem CID56846169

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACWBOI430 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXENR762 route compound structure diagram
    ACXENR762165948-24-3 In Stock
  2. Then
  3. ACWBOI430 route product structure diagram
    ACWBOI4301241725-84-7 In Stock
Inquiry

2. ACWBOI430 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWBOI430 route product structure diagram
    ACWBOI4301241725-84-7 In Stock
Inquiry

Comments (0)